Pfizer COVID-19 Vaccine Expected To Get FDA Emergency Approval For Age Group 12-15 Next Week

The Food and Drug Administration has plans to authorize the emergency use of Pfizer Inc and BioNTech SE's jointly-developed COVID-19 vaccine in adolescents aged between 12 to 15 years.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.